Graviti Pharmaceuticals Private Limited
Graviti Pharmaceuticals Private Limited appears in FDA public data with 3 recalls, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0293-2026, Class II) was initiated on January 10, 2026.
Summary
- Total Recalls
- 3
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0293-2026 | Class II | Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc. | January 10, 2026 |
| D-0037-2026 | Class II | Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. b | September 15, 2025 |
| D-0832-2020 | Class II | Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma | January 28, 2020 |